• Cost-effectiveness analyses for refractory overactive bladder- A systematic literature review

    May 1, 2013, 00:00
  • Cost-Effectiveness Of Switching To Insulin Aspart From Human Soluble Insulin In Chinese Patients With Type-2 Diabetes On A Basal-Bolus Regimen

    May 1, 2013, 00:00
  • Prevalence, Diagnosis Treatment Protocols For Breast Cancer In Southern Punjab

    May 1, 2013, 00:00
  • Distribution Outpatient Physiotherapy Services In The Different Trauma Diseases According To Major Body Parts In Hungary

    May 1, 2013, 00:00
  • Analysis of 2011 medicaid fee-for-service outpatient drug utilization, expenditures and pharmacy reimbursement rates

    May 1, 2013, 00:00
  • Racial variation in heart failure comorbidities and therapy use in a medicaid population

    May 1, 2013, 00:00
  • Colesevelam hcl or ezetimibe for hypercholesterolemia- differences in patient characteristics from a health care database

    May 1, 2013, 00:00
  • Short And Long-Term Cost-Effectiveness Of Switching Therapy From Biphasic Human Insulin 30 To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes

    May 1, 2013, 00:00
  • The Profile Of Solar Exposition And Use Of Sunscreening Agents Use Of Patients From São Paulo City With Actinic Keratosis (AK)

    May 1, 2013, 00:00
  • Discrepancies Between Fda Approval And Cms Coverage For Drugs And Devices

    May 1, 2013, 00:00
  • Analysis of consumption of antihypertensive drugs in Serbia in the period from 2006 to 2010 year

    May 1, 2013, 00:00
  • Patient-Reported Outcomes (Pros) Claims In Products Indicated For Treatment Of Non-Small-Cell Lung Carcinoma And Approved In Europe And In The United States

    May 1, 2013, 00:00
  • Incremental Health Care Resource Utilization Associated With Autosomal Dominant Polycystic Kidney Disease

    May 1, 2013, 00:00
  • The 2012 Price Trend Analysis For 12 Leading Therapy Areas In 12 Selected Developed Adn Emerging Markets

    May 1, 2013, 00:00
  • Social Networks-Based Diabetes Education Improves Social Efficacy And Cohesion, And Favors Sustainability

    May 1, 2013, 00:00
  • Comorbidities, Medications, Health Care Costs And Utilizations Of Veteran Patients With Gastroesophageal Reflux Disease In The United States

    May 1, 2013, 00:00
  • Nationwide Survey For Pharmacists On Patient Safety Culture In Japan

    May 1, 2013, 00:00
  • The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk

    May 1, 2013, 00:00
  • A descriptive analysis of drug acquisition costs to treat multiple sclerosis (MS) in brazil- The ministry of health (MOH) perspective

    May 1, 2013, 00:00
  • The canard project (projet canard) cost-effectiveness analysis of real-world outcomes in a diabetic population- The impact of baseline characteristics in France

    May 1, 2013, 00:00
  • Cost-utility analysis of spinal cord stimulation in patient with failed back surgery syndrome- Results from the precise study

    May 1, 2013, 00:00
  • Bayesian models with a weakly informative prior- a useful alternative for solving sparse data problems

    May 1, 2013, 00:00
  • Harmonization Of Health Technology Assessement And Regulatory Processes And Evidentiary Requirements For Drugs And Devices- Opportunities And Challenges

    May 1, 2013, 00:00
  • Auditing Obstetric And Newborn Referrals For Improved Quality Of Care In Northern Ghana

    May 1, 2013, 00:00
  • Sustained improvement in functional health and well-being in MDD patients following long-term treatment with Levomilnacipran SR

    May 1, 2013, 00:00
  • Vaccination coverage in colombia, opportunity and factors associated- Results from a national survey

    May 1, 2013, 00:00
  • Results of a study evaluating patient's perception regarding their erythropoiesis stimulating agent treatment in chronic kidney disease using a choice based conjoint analysis

    May 1, 2013, 00:00
  • Cost-Effectiveness Of Dexamethasone Intravitreal Implant In The Treatment Of Macular Edema (ME) Following Central Retinal Vein Occlusion (CRVO)

    May 1, 2013, 00:00
  • Budget Impact Analysis (Bia) Of Cabazitaxel Introduction In Treatment Of Metastatic Hormone-Refractory Prostate Cancer (Mhrpc) In Russian Federation

    May 1, 2013, 00:00
  • Comparison of informal care time and costs in different age-related dementias- A review

    May 1, 2013, 00:00
  • Concordance in diagnosis of diabetes between electronic medical records and claims data

    May 1, 2013, 00:00
  • The Expected Value Of Bio-Artificial Pancreas Development In View Of Endocrinologists' And Patients' Preferences

    May 1, 2013, 00:00
  • The Short- and long-term impact of consumer-driven high deductible health plans on medication use

    May 1, 2013, 00:00
  • Estimating The Potential Budget Impact Of Zelboraf (Vemurafenib) For Advanced Melanoma Treatment In Brazilian Private Health Care System

    May 1, 2013, 00:00
  • A real-world evaluation of the clinical and economic burden of veteran patients with post-traumatic stress disorder in the United States

    May 1, 2013, 00:00
  • Variability In Local Uptake And Patient Access To Medicines - Implementation Of Scottish Medicines Consortium Guidelines

    May 1, 2013, 00:00
  • Effect Of Placement Of Warning Information On OTC Drug Facts Panel- Improving Ease Of Use And Purchase Intention

    May 1, 2013, 00:00
  • The Value Of Improving Treatment Adherence In Chronic Hepatitis C Infectio

    May 1, 2013, 00:00
  • Sulfonylureas Are Associated With Elevated Risk Of Hip Fractures Among Elderly Men And Women With Type-2 Diabetes

    May 1, 2013, 00:00
  • Efficiency of dialysis centers in the united states- An updated examination of facility characteristics that influence production of dialysis treatments

    May 1, 2013, 00:00
  • Oral Glucocorticoid Use In Rituximab-Treated Rheumatoid Arthritis Patients With Prior Exposure To Anti-Tumor Necrosis Factor-Alpha Therapy

    May 1, 2013, 00:00
  • The Cost-Effectiveness Of Three Commercially Available Cellular Engineered Skin Substitutes Used To Treat Venous Leg Ulcers

    May 1, 2013, 00:00
  • Diagnostics for checking the gamma distribution assumption in generalized linear models used for modeling health care costs

    May 1, 2013, 00:00
  • Evaluation Of Survival Outcomes In Select First-Line Treatment Regimens For Advanced Nonsquamous Non-Small Cell Lung Cancer Patients

    May 1, 2013, 00:00
  • Comparing health care costs and utilizations of patients with overactive bladder who were adherent and non-adherent to their medication

    May 1, 2013, 00:00
  • Direct medical costs associated with exacerbations related to non-cystic fibrosis bronchiectasis

    May 1, 2013, 00:00
  • Health resource utilization of lupus nephritis patients – a comparison of result across case identification algorithms

    May 1, 2013, 00:00
  • To study the outcome of hospitalization in ischemic versus hemorrhagic stroke

    May 1, 2013, 00:00
  • Comparative effectiveness of antipsychotics and valproate versus antipsychotic use alone on the risk of long-term clinical outcomes and mortality in the elderly populations with Schizophrenia

    May 1, 2013, 00:00
  • Using an online data analytic tool to inform study designs for chronic disease populations- A case study with cll

    May 1, 2013, 00:00
  • The Direct Health Care Cost Of Prostate Cancer- Evidence From Us National Survey Data

    May 1, 2013, 00:00
  • The Effect Of Medicare's Chemotherapy Payment Cuts On Rituximab Use And Survival Outcomes

    May 1, 2013, 00:00
  • Women's Empowerment And Hiv Prevention In Rural Malawi

    May 1, 2013, 00:00
  • In-patient hospitalization trends for chronic kidney disease in the United States

    May 1, 2013, 00:00
  • Patterns of use of atypical antipsychotics in children and young adults

    May 1, 2013, 00:00
  • 12-month cost of illness analysis of the thyroid disease in Ukraine

    May 1, 2013, 00:00
  • Cost-of-illness studies in diabetes mellitus- A systematic review

    May 1, 2013, 00:00
  • Health-related quality of life in a portuguese cohort of patients with systemic lupus erythematosus

    May 1, 2013, 00:00
  • Productivity loss costs attributable to overweight or obesity in working asthma patients in the United States

    May 1, 2013, 00:00
  • Economic analysis of stent platforms- Cost-effectiveness of the platinum chromium promus element compared to cobalt chromium promus/xience versus everolimus-eluting stents

    May 1, 2013, 00:00
  • Use Of Biologic Agents In The Treatment Of Psoriasis- An Analysis Of The Quebec Provincial Drug Reimbursement Program Database

    May 1, 2013, 00:00
  • Whether The Treatment Expenditures Or The Pharmaceutical Expenditures Of Social Security Institution (SSI) Have A Higher Increase Rate Between 2005 And 2011 In Turkey?

    May 1, 2013, 00:00
  • Drug Interaction Lead Medication Errors - Evidence From An Indian Tertiary Care Setting

    May 1, 2013, 00:00
  • A Cost-Effectiveness Analysis Of Linezolid Versus Vancomycin For Ventilator-Associated Pneumonia Patients In Honduras

    May 1, 2013, 00:00
  • Psychometric properties of the euroqol five dimensional questionnaire (EQ-5D) in caregivers of autistic children

    May 1, 2013, 00:00
  • Adjuvant Trastuzumab Therapy In Her2-Positive Breast Cancer Patients- A Meta-Analysis Of Published Randomized Trials

    May 1, 2013, 00:00
  • Utility evaluation of health states related to stroke and stroke prophylaxis

    May 1, 2013, 00:00
  • Persistence with glaucoma therapy in a lrage health organization in Israel

    May 1, 2013, 00:00
  • N-acetylcysteine for polycystic ovary syndrome- A systematic review and meta-analysis of randomised controlled clinical trials

    May 1, 2013, 00:00
  • The value of value in health economic modelling

    May 1, 2013, 00:00
  • Bridging HTA Agencies Across Europe- A Systematic Approach To Categorize Evolving Agencies

    May 1, 2013, 00:00
  • Economic Evaluation Of Aclidinium Bromide In The Management Of Moderate-To-Severe Copd

    May 1, 2013, 00:00
  • Assessing The Clinical And Economic Burden Of Veteran Diabetes Patients In The United States

    May 1, 2013, 00:00
  • Who told you that- Do guidelines for including patient-centered outcome measures in systemic lupus erythematosus clinical trials include patient input?

    May 1, 2013, 00:00
  • A Study On The Impact Of Code Availability And Valuation On Successful Market Access For New Dermatological Products And Procedures In The US

    May 1, 2013, 00:00
  • The Effect Of Massachusetts Health Care Reform On Inpatient And Emergency Department Use

    May 1, 2013, 00:00
  • Distribution of left ventricle ejection fraction (LVEF), patient attributes, and medication use in heart failure patients in a us electronic medical record database

    May 1, 2013, 00:00
  • A Critical Review Of Ema Labeling Claims In Oncology- 2006-2012

    May 1, 2013, 00:00
  • Assessing The Impact Of Patient-Reported Outcomes And Health Economic Benefit Claims On The Market Value Of Oncologic Pharmaceuticals

    May 1, 2013, 00:00
  • Impact Of Primary Care Availability On Hospital Inpatient Use By Insurance Status

    May 1, 2013, 00:00
  • The role of socio-economic factors in the non renewal decision making of national health insurance policy holders in the bekwai municipal

    May 1, 2013, 00:00
  • Quality Of Life In Women With Cervical Precursor Lesions And Cancer- A Hospital-Based Study

    May 1, 2013, 00:00
  • The case-referent study- are difficulties in its reporting and interpretation affecting non-rct systematic reviews? Would an extension to strobe help?

    May 1, 2013, 00:00
  • New oral anticoagulants versus warfarin for stroke prevention in atrial fibrillation- Development of coverage decision frameworks

    May 1, 2013, 00:00
  • Vulvar Cancer-Related Hospitalizations In The United States- A Retrospective Population-Based Case-Control Study

    May 1, 2013, 00:00
  • Budget impact analysis of quetiapine versus aripiprazole or olanzapine on the top of standard therapy in the treatment of bipolar disorder in Russian Federation

    May 1, 2013, 00:00
  • Perspectives on complementary data sources in diabetes health technology assessment- An enrolling practice-based research network and a large commercial health plan

    May 1, 2013, 00:00
  • Refining The Risk-Adjusted Capitated Payment Methodologies For Medicare Part C (CMS-HCC) And Part D (CMS-RXHCC) Plans Using The Medication Exposure Measure (MEM)

    May 1, 2013, 00:00
  • High-risk vascular disease in japan- evidence on incidence, patient characteristics, and treatment rates from a large Japanese claims database

    May 1, 2013, 00:00
  • A model utilizing preoperative markers to predict patients associated with high cost in open versus endovascular repair of non-ruptured abdominal aortic aneurysm

    May 1, 2013, 00:00
  • Clinical and economic burden of atrial fibrillation in medicare beneficiaries with acute coronary syndrome

    May 1, 2013, 00:00
  • Burden of influenza disease in the united kingdom (uk)- A linked general practice research database (gprd) analysis

    May 1, 2013, 00:00
  • Structured review of patient-reported outcome instruments for assessing patients with atrial fibrillation

    May 1, 2013, 00:00
  • Towards a paradigm shift in anticoagulation? too soon to conclude on cost-effectiveness of new anticoagulants

    May 1, 2013, 00:00
  • Beyond Average Adheren Temporal Patterns Of Medication Adherence Predict Hospitalization Risk More Accurately Than The Medication Possession Ratio

    May 1, 2013, 00:00
  • Establishing a weighting methodology to compute the number of patients with disease using claims data and census population in the united states

    May 1, 2013, 00:00
  • Matching-adjusted indirect comparison of lipid profile at 48 weeks among treatment naïve HIV-1 patients treated with Atazanavir/Ritonavir versus Darunavir/Ritonavir

    May 1, 2013, 00:00
  • The Economic Value Of An Innovative Knee Implant System For Total Knee Arthroplasty

    May 1, 2013, 00:00
  • Estimating the costs of cardiac rehabilitation programs in heart failure (HF) in colombia- construction based on expert consensus

    May 1, 2013, 00:00
  • Work productivity after LAP-BAND AP® system implantation in obese patients - one year results of the helping evaluate reduction in obesity (HERO) study

    May 1, 2013, 00:00
  • Examination of preferences elicited from the general public- Subgroup comparisons of results from the time trade-off and standard gamble instruments

    May 1, 2013, 00:00
  • Trends In Use Of Health Economic Evidence For Developing Clinical Guidelines

    May 1, 2013, 00:00
  • A Comparison Of New Drugs Approved By The EMA and the FDA in 2006–2011

    May 1, 2013, 00:00
  • Health utility assessment using EQ-5D among caregivers of children with Autism

    May 1, 2013, 00:00
  • Potential Epidemiological And Economic Impact Of Different Rotavirus Vaccines In Low And Middle Income Countries

    May 1, 2013, 00:00
  • Use Of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers And Risk Of Dementia In Heart Failure

    May 1, 2013, 00:00
  • Cost-Effectiveness Of Eml4-Alk Fusion Testing In Combination With Crizotinib Treatment For Patients With Advanced Non-Small Cell Lung Cancer Living In Ontario

    May 1, 2013, 00:00
  • Comparing vaccine effectiveness estimates in cost-effectiveness analyses of pneumococcal vaccination in adults

    May 1, 2013, 00:00
  • Are Quality Improvements Sustained? Long-Term Effectiveness Of A Physician-Focused Intervention To Reduce Potentially Inappropriate Medication Prescribing In The Elderly In Italy

    May 1, 2013, 00:00
  • Cost Analysis Of Skeletal Related Events Among Elderly Men With Stage Iv Metastatic Prostate Cancer In Seer-Medicare

    May 1, 2013, 00:00
  • Disease modifying therapy and the risk of hospitalization in patients with heart failure- A contemporary medicaid cohort analysis

    May 1, 2013, 00:00
  • Abdominal Aortic Aneurysm Screening- The Impact Of The SAAAVE Act Of 2007

    May 1, 2013, 00:00
  • Introduction Of A Low-Dose Levonorgestrel Intrauterine Contraceptive System- A Three-Year Budget Impact Analysis From A Third-Party Payer Perspective In The United States

    May 1, 2013, 00:00
  • Health care resource utilization patterns associated with belimumab in patients with systemic lupus erythematosus- Results from observe study in the United States

    May 1, 2013, 00:00
  • Comparative Analysis Of Radium-223 Versus Placebo In Symptomatic Metastatic Castration Resistant Prostate Cancer Treated With Best Standard Of Care On Skeletal-Related Events Outcomes

    May 1, 2013, 00:00
  • First Results Provided By The Russian Registry Of Breast Cancer Patients

    May 1, 2013, 00:00
  • Qualitative development and cognitive evaluation of the symptoms of major depressive disorder (s-mdd), a consortium-developed patient reported outcome measure

    May 1, 2013, 00:00
  • Transfusions in patients who underwent open spine fusion versus minimally invasive spine fusion based on a premier perspective® database sample

    May 1, 2013, 00:00
  • Getting To Better Value From Medical Devices- Reimbursement And Pricing Policies In Europe And The United States

    May 1, 2013, 00:00
  • Impact Of Pharmacists Led Health Education Programme On Health-Related Quality Of Life In Pakistani Hepatitis-B Patients

    May 1, 2013, 00:00
  • Integrated care programs in Europe- Factors of success

    May 1, 2013, 00:00
  • Development of an algorithm that differentiates among risk factors, comorbidities, and consequences of disease in peer-reviewed publications

    May 1, 2013, 00:00
  • Economic Evaluations Of Companion Diagnostics In Cancer Therapy

    May 1, 2013, 00:00
  • Excess Risks And Costs Of Invasive Pneumococcal Disease And Pneumonia Among Us Persons With Underlying Medical Conditions

    May 1, 2013, 00:00
  • Preparation of a hospital dataset for analysis prior to a hospital and health insurer merger

    May 1, 2013, 00:00
  • Texas community pharmacists' views and actions regarding dispensing controlled prescription drugs

    May 1, 2013, 00:00
  • The Impact Of Opioid-Induced Constipation (Oic) On Quality Of Life – A 10-Year Literature Review

    May 1, 2013, 00:00
  • Key cost drivers in the cost of care for sickle cell disease patients- Results of a systematic literature search and a survey of payers and key opinion leaders

    May 1, 2013, 00:00
  • A method to estimate disease-stage-specific survival using data obtained from a prevalent cohort

    May 1, 2013, 00:00
  • Effects of phentermine and topiramate extended-release (PHEN/TPM ER) treatment on weight loss (WL) when stratified by baseline body mass index (BMI) over 1 year

    May 1, 2013, 00:00
  • Cost Effectiveness Analysis Of Tenofovir Disoproxil Fumarate (Viread®) In The Treatment Of Patients With Chronic Hepatitis B (Chb) In Mexico

    May 1, 2013, 00:00
  • Hospital budget impact of readmission penalties and bundled payments- Potential impact of coronary stent platforms

    May 1, 2013, 00:00
  • Identifying schizophrenia patients at high-risk for hospitalization using the assessment for quality improvement and risk evaluation tool

    May 1, 2013, 00:00
  • Prevalence And Incidence Of Acute Urogenital Conditions In A Us Commercially-Insured Population

    May 1, 2013, 00:00
  • An incidence model of the cost of advanced prostate cancer in Spain

    May 1, 2013, 00:00
  • Changes in pain intensity and healthrelated quality of life (HRQOL) in patients with peripheral neuropathic pain after treatment with 8% capsaicin patch – results from a nordic prospective observational study

    May 1, 2013, 00:00
  • Can we determine the optimal cycle length for which half-cycle correction should always be applied?

    May 1, 2013, 00:00
  • Treatment of renal transplantation in brazil after the loss of tacrolimus patent- A cost-effectiveness analysis

    May 1, 2013, 00:00
  • Use Of The Functional Assessment Of Cancer Therapy-Anemia (Fact-An) Instrument In Persons With Mpn-Associated Myelofibrosis And Anemia

    May 1, 2013, 00:00
  • The impact of receiving face-to-face medication therapy management (MTM) services on adherence to chronic medications- A retrospective claims analysis

    May 1, 2013, 00:00
  • Gemifloxacin as first line treatment for community acquired pneumonia in mexico- A cost—effectiveness study

    May 1, 2013, 00:00
  • Benchmarks for interpretation of score differences on the SF-36 health survey

    May 1, 2013, 00:00
  • Cost-effectiveness of catheter ablation versus antiarrhythmic drug therapy for the treatment of atrial fibrillation in canada

    May 1, 2013, 00:00
  • Polypharmacy And Self-Perceived Health Status In Older Patients

    May 1, 2013, 00:00
  • Opioid Abstinence In Opioid Dependent Patients Infected With HCV In Treatment With Buprenorphine

    May 1, 2013, 00:00
  • Estimating the cost-effectiveness of onabotulinumtoxinA for neurogenic detrusor overactivity in the United States

    May 1, 2013, 00:00
  • Egfr Test-Guided Erlotinib Versus Chemotherapy For First-Line Treatment Of Advanced Non-Small Cell Lung Cancer- A Budget Impact Analysis

    May 1, 2013, 00:00
  • Is Denosumab Cost-Effective Compared To Oral Bisphosphonates For The Treatment Of Male Osteoporosis (Mop) In Sweden?

    May 1, 2013, 00:00
  • The cost–effectiveness of rivaroxaban for the prevention of stroke in patients with atrial fibrillation (AF) in Turkey

    May 1, 2013, 00:00
  • Cost-effectiveness of ticagrelor in patients with acute coronary syndrome

    May 1, 2013, 00:00
  • Measuring Health Outcomes In The Absence Of Rigour- Willful Ignorance Or Deliberate Malpractice?

    May 1, 2013, 00:00
  • The Disease Burden Of Pediatric Atopic Dermatitis Across 12 Countries In The Asia Pacific Region

    May 1, 2013, 00:00
  • Lead versus lag time trade-off variants- does it make any difference?

    May 1, 2013, 00:00
  • Cost effectiveness and cost utility analyses of ivabradine (procoralan®) in the treatment of patients with chronic heart failure in Mexico

    May 1, 2013, 00:00
  • Comparative risks of severe cutaneous reactions, aseptic meningitis, and organ dysfunction associated with antiepileptic drugs

    May 1, 2013, 00:00
  • Evaluation of pharmacological management for type-2 diabetes post-myocardial infarction

    May 1, 2013, 00:00
  • Budget Impact Analysis Of The Introduction Of Saxagliptin/Metformin Extended-Release (Xr) In The Treatment Of Type-2 Diabetes In Chile

    May 1, 2013, 00:00
  • Prevalence of depressive symptoms and predictors of treatment among adults from 2005 to 2010 in the United States

    May 1, 2013, 00:00
  • Quality Indicators Of The Third Screening Round (2006-2007) Of The Hungarian Organized, Nationwide Breast Cancer Screening Program

    May 1, 2013, 00:00
  • Exploring the humanistic and economic burden of crohn's disease- Considerations for novel compounds

    May 1, 2013, 00:00
  • Evaluation of comparative cost analysis of renal replacement therapies

    May 1, 2013, 00:00
  • Expenditure and effectiveness of treatment options in chronic myeloid leukemia patients who failed in the first-line imatinib treatment

    May 1, 2013, 00:00
  • Warfarin dose adjustments due to drug-drug interaction with dronedarone- A case-control study

    May 1, 2013, 00:00
  • Study Of The Treatment Patterns In Metastatic Breast Cancer Patients In A Tertiary Care Hospital

    May 1, 2013, 00:00
  • A systematic review of the network meta-analysis literature

    May 1, 2013, 00:00
  • Health Technology Assessment Landscape Of Biosimilars – Approaches To Evaluations And Results

    May 1, 2013, 00:00
  • Cost-utility of two short-term psychotherapies in the treatment of depressive and anxiety disorders during a three-year follow-up

    May 1, 2013, 00:00
  • Ispor 18thAnnual International Meeting Financial Disclosure Information For Research Presentations

    May 1, 2013, 00:00
  • Impact of automated telephonic reminders on patient on-time medication refills- Initial findings of a randomized study

    May 1, 2013, 00:00
  • Challenges in assessing the impact of hyponatremia management on length of stay- Interim results from a global, multi-center, prospective, observational registry of hospitalized hypervolemic and euvolemic hyponatremic patients

    May 1, 2013, 00:00
  • Rapid Improvements In Patient-Reported Outcomes With Certolizumab Pegol In Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis And Non-Radiographic Axial Spondyloarthritis- 24-Week Results Of A Phase 3 Double Blind Rando ...

    May 1, 2013, 00:00
  • Waking at night to void can have a profound impact on productivity

    May 1, 2013, 00:00
  • Impact Of Hormone Receptor Status And Her2 On Survival Of Triple Negative Breast Cancer Patients

    May 1, 2013, 00:00
  • Impact of asthma education on health related quality of life (HRQoL) measures

    May 1, 2013, 00:00
  • Economic burden of adverse treatment effects in parkinson's disease- Evidence from a large employer population

    May 1, 2013, 00:00
  • Economic Burden Of Osteoporotic Fracture In Elderly In South Korea

    May 1, 2013, 00:00
  • Tools used to improve medication adheren a systematic review

    May 1, 2013, 00:00
  • Modeling diabetes costs- A comparison of econometric methods using simulated error distributions

    May 1, 2013, 00:00
  • Why are the findings of cost-effectiveness analyses of biologic treatment for rheumatoid arthritis so different?

    May 1, 2013, 00:00
  • Burden of schizophrenia in texas

    May 1, 2013, 00:00
  • Direct medical cost and quality of life of diastolic heart failure in Hong Kong

    May 1, 2013, 00:00
  • Once-a-day extended-release versus two-times-daily immediate-release methylphenidate for the treatment of adhd - A cost minimization study

    May 1, 2013, 00:00
  • Factors influencing physicians' prescribing behavior associated with prescribing poly-pharmacy antidepressant drugs

    May 1, 2013, 00:00
  • Geographical Differences In The Utilization Of Dental Services In Hungary

    May 1, 2013, 00:00
  • How big is the difference between marginal cost versus total cost estimates? the case of ischemic stroke in south carolina (SC)

    May 1, 2013, 00:00
  • Comparison Of Clinical Characteristics Of Patients With Rheumatoid Arthritis (Ra) Receiving Their First Biologic In Uk, Germany, France, Italy And Spain (5eu)

    May 1, 2013, 00:00
  • “Safe And Effective” Versus “Reasonable And Necessary”- Is The Deck Stacked Against Devices?

    May 1, 2013, 00:00
  • Cost-utility of hpv for prevention of cervical cancer in the roraima (Brazilian Amzonic region)- A Markov model approach

    May 1, 2013, 00:00
  • Infliximab compliance estimates from medical chart and administrative claim databases- A methodological comparison

    May 1, 2013, 00:00
  • Health Related Quality Of Life In A National Sample Of Caregivers – A Multilevel Analysis

    May 1, 2013, 00:00
  • Cost-Effectiveness Of Prophylaxis Treatment Strategies For Febrile Neutropenia In Recurrent Ovarian Cancer Patients

    May 1, 2013, 00:00
  • Multi-national retrospective chart review studies- Lessons learned from application of methodology to international evaluations of burden of illness and drug utilization and safety

    May 1, 2013, 00:00
  • Adherence to oral anti-diabetic medications in antipsychotic medication users and non-users

    May 1, 2013, 00:00
  • A literature review of the variance in interval length between administrations for assessment of test retest reliability and equivalence of pro measures

    May 1, 2013, 00:00
  • Use Of An Electronic Health Record (Ehr) Database To Study Drug Resistance Among Hospitalized Patients With Complicated Intra-Abdominal Infection (Ciai)

    May 1, 2013, 00:00
  • Economic burden of otitis media among children in the United States- Results from a national database

    May 1, 2013, 00:00
  • State-level, population-based cancer registry and administrative data linkages in the united states- A review of the literature

    May 1, 2013, 00:00
  • Reimbursement Landscape And Policy Development For Rare Diseases In China- A Case Study Of Hemophilia

    May 1, 2013, 00:00
  • Impact of multiple treatment comparison meta-analysis on value of information evaluations- a case study of pharmacotherapies for chronic obstructive pulmonary diseases

    May 1, 2013, 00:00
  • Patient And Physician Preferences In The United States For Benefits And Risks Of Anticoagulant Use In Atrial Fibrillation – Results From A Conjoint-Analysis Study

    May 1, 2013, 00:00
  • Impact of atypical antipsychotic use on the persistence of the stimulant treatment in children and adolescents with attention deficit/hyperactivity disorder

    May 1, 2013, 00:00
  • Correlates of improvement in physical quality of life and quality of sleep among chronic low back pain patients with treatment with buprenorphine transdermal system (BTDS)

    May 1, 2013, 00:00
  • Relationship Between Self-Monitoring Of Blood Glucose And Treatment Progression In Patients With Type 2 Diabetes Mellitus

    May 1, 2013, 00:00
  • Cost-effectiveness of newer anticoagulants for stroke prevention in atrial fibrillation- A systematic literature review

    May 1, 2013, 00:00
  • Cost-effectiveness of atypical antipsychotics for the treatment of relapse prevention for bipolar disorder- The russian perspective

    May 1, 2013, 00:00
  • Hospital Center Effect For Laparoscopic Colectomy Among Elderly Stage I-Iii Colon Cancer Patients

    May 1, 2013, 00:00
  • Comparison In Length Of Hospital Stay Related To The Diagnosis Of Copd Patients Before And After A Program Of Pharmacotherapy Monitoring

    May 1, 2013, 00:00
  • Projected Economic Impact Of Current And Future Chronic Hepatitis C Treatment Regimens And Recent Screening Guidelines In The United States

    May 1, 2013, 00:00
  • Direct health care costs in patients with pulmonary arterial hypertension in the national institute of cardiology "ignacio chávez" (nic), mexico city

    May 1, 2013, 00:00
  • Osteoarthritis is an independent risk factor for higher event rate of major adverse cardiovascular outcomes in hypertensive patients – from 15-year taiwan nhird database

    May 1, 2013, 00:00
  • Comparison Of Cost Per Qaly (Quality-Adjusted Life Year) For Major Types Of Cancers, End-Stage Renal Disease And Rheumatoid Arthritis In Taiwan- A Population-Based Study During 1998-2007

    May 1, 2013, 00:00
  • Variation in statin intensity prescribing post-acute myocardial infarction by baseline patient complexity

    May 1, 2013, 00:00
  • The Effect Of Smoking On Healing Of Tibia Fractures- A Bayesian Meta-Analysis

    May 1, 2013, 00:00
  • Relationships Among Symptomatic Hypoglycemia, Patient-Reported Fear Of Hypoglycemia And Health-Related Quality Of Life (Hrqol) In Type-2 Diabetes Mellitus (T2dm) Patients

    May 1, 2013, 00:00
  • Willingness to pay for diagnostic technologies- A review of the contingent valuation literature

    May 1, 2013, 00:00
  • Cost-effectiveness of onabotulinumtoxinA for prophylaxis of headaches in adults with chronic migraine in Canada

    May 1, 2013, 00:00
  • Insulin Administration And The Impacts Of Forgetting A Dose For Patients

    May 1, 2013, 00:00
  • EU Pharmaceutical Expenditure Forecast

    May 1, 2013, 00:00
  • Cost effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction- a post- hoc analysis of the smile-4 study

    May 1, 2013, 00:00
  • Examination of treatment patterns of ankylosing spondylitis patients in the veterans affairs and medicare databases using a visualization tool

    May 1, 2013, 00:00
  • Applied Contributions To The Eq-5D Health Utility Index

    May 1, 2013, 00:00
  • Adherence And Its Association With Health Outcomes Among Patients Currently Treated For Leukemia, Melanoma, Or Non-Small Cell Lung Cancer (Nsclc)

    May 1, 2013, 00:00
  • The Use Of Complementary And Alternative Medicines (Cam) Among Patients With Cancer- A Descriptive Study

    May 1, 2013, 00:00
  • ABC Analysis Of Pharmaceuticals In A Resource Limited Rural Hospital In India

    May 1, 2013, 00:00
  • Novel Reimbursement Models For Cancer Drug Market Access (2010-2013)

    May 1, 2013, 00:00
  • Interviews With Patients With Chronic Hepatitis C (CHC) Virus Infection Document Unmet Needs, Content Validity, And Comprehension Of Pros For Clinical Trials

    May 1, 2013, 00:00
  • Cost of angioplasty in Brazilian private hospitals

    May 1, 2013, 00:00
  • An adaptable methodology for the design, implementation and conduct of a web-based survey assessing burden of illness and racial differences- Case study of adult females with ACNE

    May 1, 2013, 00:00
  • Frequency and economic impact of comorbid cardiac conditions among hospitalizations of patients with multiple sclerosis

    May 1, 2013, 00:00
  • Cost-Utility Analysis Of Tocilizumab In The Treatment Of Active Systemic Juvenile Idiopathic Arthritis

    May 1, 2013, 00:00
  • Patterns of non-administration of ordered doses of venous thromboembolism prophylaxis- implications for novel intervention strategies

    May 1, 2013, 00:00
  • Recruiting patients with a rare blood disorder and their caregivers through social media

    May 1, 2013, 00:00
  • The impact of cigarette smoking on mortality for diabetic patients- A propensity score matching approach

    May 1, 2013, 00:00
  • Economic Evaluation Of Breast Cancer Prevention Agents- Comparing Tamoxifen, Raloxifene And Exemestane

    May 1, 2013, 00:00
  • Cost-Effectiveness Evaluation Of Amphotericin B, Amphotericin B Liposomal, Caspofungin And Voriconazol In Treating Aspergillosis Under The Brazilian Private Health Care System Perspective

    May 1, 2013, 00:00
  • Cost to society due to underemployment in persons with hemophilia A and B – hemophilia utilization group study v (HUGS V)

    May 1, 2013, 00:00
  • Indicators Of Quality Drug Supply Within The Framework Of The Guaranteed Volume Of Free Medical Care In The Regions Of Kazakhstan

    May 1, 2013, 00:00
  • The Impact Of Korean Prospective Drug Utilization Review Program On The Rate Of Drug-Drug Interactions

    May 1, 2013, 00:00
  • Rapid economic evaluation review for rare diseases treatments – The case of pegvisomant for acromegaly

    May 1, 2013, 00:00
  • Clinical Care Path And Costs Associated With Managing Patients With Prolonged Air Leaks After Thoracic Lung Volume Reduction Surgery- A Review Of The Literature

    May 1, 2013, 00:00
  • Costs and health care resource utilization associated with asthma in canada- A systematic review

    May 1, 2013, 00:00
  • Predicting medication adherence using retail pharmacy data

    May 1, 2013, 00:00
  • The Impact Of Memory Problems On Diabetes Treatment In China

    May 1, 2013, 00:00
  • Recurrence and risk factors in hospitalized patients with acute venous thromboembolism- A claims database analysis

    May 1, 2013, 00:00
  • The Use Of Repeat Screening Colonoscopy In A Nationwide Privately Insured Population

    May 1, 2013, 00:00
  • A profiling of hypertension patients treated with chlorthalidone or hydrochlorothiazide

    May 1, 2013, 00:00
  • Initial assessment of real-world usage of extended-release injectable paliperidone palmitate among medicaid insured schizophrenia patients

    May 1, 2013, 00:00
  • Health Care Resource Utilization, Costs, And Adverse Events In The Outpatient Treatment Of Aspergillosis With Voriconazole In The United States

    May 1, 2013, 00:00
  • Cross-cultural adaptation of a research version of the rey auditory verbal learning test (RAVLT) into japanese

    May 1, 2013, 00:00
  • Using classical psychometric testing and rasch analysis to refine a new weight specific quality of life measure for adolescents

    May 1, 2013, 00:00
  • Building the infrastructure for conducting pragmatic trials in a learning health care system

    May 1, 2013, 00:00
  • Cost-Effectiveness Of Lapatinib In Metastatic Breast Cancer- A Middle Income Perspective

    May 1, 2013, 00:00
  • The use of antimicrobial impregnated catheter to prevent shunt-related cerebrospinal fluid infection in canadian hospitals- An economic analysis

    May 1, 2013, 00:00
  • Comparison of patient characteristics and health care utilization in epilepsy patients adding adjunctive lacosamide to sodium channel blockers versus non-sodium channel blockers

    May 1, 2013, 00:00
  • Clinical outcome assessments and rater training materials - maximizing consistency

    May 1, 2013, 00:00
  • Assessing health related quality of life in persons with diabetes- Variations among six generic indexes

    May 1, 2013, 00:00
  • Treatment Related Severe Hypoglycaemia Risk In Diabetes Type-1 And Type-2–A Systematic Review Of Observational Studies

    May 1, 2013, 00:00
  • Comparison Of Disease Status And Outcomes Of Patients With Psoriatic Arthritis (Psa) Receiving Their First Biologic In Uk, Germany, France, Italy And Spain (5eu)

    May 1, 2013, 00:00
  • Predictors of willingness to quit smoking among a cohort of male college students in the Kingdom of Saudi Arabia

    May 1, 2013, 00:00
  • Conducting patient-centered studies- Challenges and opportunities

    May 1, 2013, 00:00
  • Atrial fibrillation prevalence associated with geographic variation and age in the united states veteran population

    May 1, 2013, 00:00
  • Cross-cultural adaptation of the HAEMO-QOL questionnaire into 28 languages

    May 1, 2013, 00:00
  • The effect of vortioxetine (LU AA21004) on health-related quality of life (HRQOL) in patients with major depressive disorder (MDD)

    May 1, 2013, 00:00
  • Copd Prevalence And Costs Value In Ukraine

    May 1, 2013, 00:00
  • The potential cost savings associated with preventing the development of hypertension, diabetes and dyslipidemia in an overweight and obese population

    May 1, 2013, 00:00
  • Budget impact of pregabalin for the treatment of neuropathic pain in Colombia

    May 1, 2013, 00:00
  • Exploring Differences Across The Independent Academic Centres In The Outcomes Of The Nice Appraisal Process

    May 1, 2013, 00:00
  • Cost effectiveness of Sativex for spasticity in multiple sclerosis

    May 1, 2013, 00:00
  • A cost-effectiveness analysis of extending methadone and buprenorphine-naloxone maintenance treatment of opioid dependence from eight to sixteen months

    May 1, 2013, 00:00
  • Compliance With The Birth Dose Of Hepatitis B Vaccine In High Endemic And Hard To Reach Areas In Colombiaa

    May 1, 2013, 00:00
  • Total costs of care in the 90 days following emergency department visits for patients taking exclusively class-II or class-III short-acting opioids

    May 1, 2013, 00:00
  • Effectiveness of step therapy policies for specialty pharmaceuticals in immune disorders

    May 1, 2013, 00:00
  • Development Of A Multi-Dimensional Health Related Quality Of Life Measure Specific For Pulmonary Tuberculosis Patients In Iraq

    May 1, 2013, 00:00
  • Clinical characteristics in Mexican adult patients with herpes encephalitis

    May 1, 2013, 00:00
  • Assessing The Clinical And Economic Burden Of Prostate Cancer In The Veteran Population In The United States

    May 1, 2013, 00:00
  • Why are the findings of indirect comparisons of boceprevir and telaprevir for hepatitis C infection different? A methodological review

    May 1, 2013, 00:00
  • Improvements In Productivity At Paid Work And Within Household, And Increased Participation In Daily Activities After 24 Weeks Of Certolizumab Pegol Treatment Of Patients With Psoriatic Arthritis- Results Of A Phase 3 Double Blind Randomize ...

    May 1, 2013, 00:00
  • Evaluation Of Outpatient Health Care And Medication Utilization In Patients With Human Immunodeficiency Virus/Hepatitis C Virus (Hiv/Hcv), Hiv, Or Hcv Infection In The United States

    May 1, 2013, 00:00
  • Cost Analysis Of 418fdg-Pet/Ct At The Perspective Of Brazilian Health Care System As Service Provider- Study In A Public Health Unit In Rio De Janeiro

    May 1, 2013, 00:00
  • Clinical and economic impact of five-year adherence to disease-modifying therapies in a commercially insured multiple sclerosis population

    May 1, 2013, 00:00
  • Resource use patterns and costs associated with the treatment of myelofibrosis, polycythemia vera and essential trombocythemia in the brazilian public health care system

    May 1, 2013, 00:00
  • Patient Preferences- Understanding Risk-Benefit Trade-Offs Of Genomic Testing In Chemotherapy Decisions For Breast Cancer Patients

    May 1, 2013, 00:00
  • Pharmacist-led services to patients with respiratory diseases- Feasible from a quality and reimbursement perspective?

    May 1, 2013, 00:00
  • Critical Appraisal Of The Financial Impact Of Implementing The Rules Of Resolution Of Brazilian Chamber Of Economic Regulation Of Pharmaceuticals (CMED) N° 2/2004 On The Prices Of New Medicines In Brazil

    May 1, 2013, 00:00
  • Economic burden of acute urogenital conditions among type ii diabetes patients and non-diabetics in the United States

    May 1, 2013, 00:00
  • A review on individual simulation (ils) method used in nice economic evaluations for recent oncology medicines

    May 1, 2013, 00:00
  • Matching-adjusted indirect comparisons- A simulation study of statistical performance

    May 1, 2013, 00:00
  • Predicting A Patient's Future Medical Visits- A Comparison Of Quality Of Life And Clinical Variables

    May 1, 2013, 00:00
  • Adherence To Insulin Theapy May Substantially Reduce Costs Associated With Health Resource Utilization Among Insulin Pen Users With Type Ii Diabetes Mellitus

    May 1, 2013, 00:00
  • Do Patients Need To Be Accompanied In ICU Wards?

    May 1, 2013, 00:00
  • Meta-Analysis For Efficacy Of Etanercept For Treatment Of Psoriatic Arthritis

    May 1, 2013, 00:00
  • Validation And Comparison Of The SF-6D And EQ-5D In Chinese Patients With Moderate To Severe Psoriasis

    May 1, 2013, 00:00
  • Health Care Resource Utilization And Costs Of Patients With Aspergillosis In The United States

    May 1, 2013, 00:00
  • Estimated Cost Savings Associated With A1c Reductions In A Large Us Commercial Health Plan

    May 1, 2013, 00:00
  • Gaps In Us And Eu Payer Policies Limit Theapeutic Options In Pain Conditions

    May 1, 2013, 00:00
  • Do you need to account for baseline viral load when assessing the relative efficacy of interventions for treatment naïve hbeag positive chronic hepatitis b (chb) patients? results from unadjusted and adjusted network meta-analyses (nma)

    May 1, 2013, 00:00
  • Estimating The Budget Impact Of Adding Omalizumab To Standard Therapy In Patients With Uncontrolled Severe Allergic Asthma From Private Health Care System Perspective In Brazil

    May 1, 2013, 00:00
  • Awareness and beliefs about pneumococcal and influenza vaccination among older african americans- Results from a survey of community-dwelling participants at an urban senior center

    May 1, 2013, 00:00
  • Adjuvant And Salvage Radiation Treatment After Prostatectomy- Comparing Italian And United States Radiation Oncologists' Practice Attitudes

    May 1, 2013, 00:00
  • Value Associated With Pharmacy And Medical Benefit Integration In A Commercially Insured Diabetic Population

    May 1, 2013, 00:00
  • Hospitalization Costs Related To Pulmonary Hypertension (Ph) Among Medicare Advantage Or Commercially Insured Patients With Pulmonary Arterial Hypertension (Pah) In The United States

    May 1, 2013, 00:00
  • Patient Reported Outcomes In Metastatic Castration-Resistant Prostate Cancer- A Systematic Review

    May 1, 2013, 00:00
  • Patient preferences for the treatment of type-2 diabetes- A scoping review and assessment of methods

    May 1, 2013, 00:00
  • Frequency and effect sizes of risk factors associated with initial medication adherence

    May 1, 2013, 00:00
  • Assessing The Consistency Of Absolute Cardiovascular Risk Prediction And Relative Risk Reduction In Type-2 Diabetes Mellitus

    May 1, 2013, 00:00
  • Prevalence Of Chronic Hepatitis C Virus And Commonly-Associated Comorbidities Within A Large Us Commercially-Insured Population

    May 1, 2013, 00:00
  • Using Chart Review Methodology To Characterize Patients, Treatment Patterns And Clinical Outcomes In A Cohort Of Patients With Castleman's Disease

    May 1, 2013, 00:00
  • Utilization Of Home Care (Nursing) Services In Hungary

    May 1, 2013, 00:00
  • Associations Between Claims Based Adherence, Weight Loss And, Glycemic Control In Patients With Type 2 Diabetes

    May 1, 2013, 00:00
  • Reducing Budget Impact To Mexican Public Health Care System With The Usage Of A Novel Glp-1 Analogue For Uncontrolled T2dm Patients On Basal Insulin Regimen

    May 1, 2013, 00:00
  • Dispensing Practices At Community Pharmacies- A Cross Sectional Study From Pakistan

    May 1, 2013, 00:00
  • Predictors of use of atypical antipsychotics and long acting stimulants polypharmacy among children and adolescents with attention deficit hyperactivity disorder

    May 1, 2013, 00:00
  • Fatigue Severity Scale- Reliability, Validity And Interpretation Of Change -- Evidence From Two Clinical Trials In Patients With Chronic Hcv Infection

    May 1, 2013, 00:00
  • The Importance Of Managing Arthritis In Patients With Both Moderate-To-Severe Psoriasis And Psoriatic Arthritis

    May 1, 2013, 00:00
  • Direct medical costs for complications among adults with type 2 diabetes in a us commercial payer setting

    May 1, 2013, 00:00
  • Connectedcare for MS- Impact of managed therapy on adherence to multiple sclerosis medications

    May 1, 2013, 00:00
  • Comparative effectiveness research on the new anticoagulants- is it worth it?

    May 1, 2013, 00:00
  • Analysis of the impact of prescription synchronization on adherence among medicaid beneficiaries

    May 1, 2013, 00:00
  • Common pregnancy symptoms increase the risk of cardiovascular disease

    May 1, 2013, 00:00
  • The Benefits Of Hospital Specialization- Effects On Clinical Quality And Financial Performance

    May 1, 2013, 00:00
  • Cost effectiveness analysis of rosuvastatin 5mg in the treatment of adult patients with hypercholesterolemia in Mexico

    May 1, 2013, 00:00
  • Cost Of Failed Labor Induction- A Us Hospital Perspective

    May 1, 2013, 00:00
  • Effectiveness Of Second Line Biologic Use In Rheumatoid Arthritis After Switching From First-Line Biologics

    May 1, 2013, 00:00
  • Prevalence And Incidence Of Pathologic Myopia And Retinal Neovascularization In A US Managed Care Database

    May 1, 2013, 00:00
  • Prevalence And Risk Factors Of Diabetic Peripheral Neuropathy In Type 2 Diabetes Mellitus Out-Patients

    May 1, 2013, 00:00
  • One month after treatment initiation nocturia patients slept significantly longer and better on treatment than placebo patients

    May 1, 2013, 00:00
  • Are The Rich Different With Regard To Prescription Drug Utilization?

    May 1, 2013, 00:00
  • The Pain Assessment For Lower Back Impacts (PAL-I)- Qualitative Development And Cognitive Evaluation Of A New Patient Reported Outcome Measure For The Assessment Of Impacts Of Low Back Pain

    May 1, 2013, 00:00
  • Trends In Prescription Drug Utilization Among Beneficiaries With Private Insurance

    May 1, 2013, 00:00
  • Outpatient treatment patterns for Schizophrenia in the United States- A nationally representative analysis using NAMCS and NHAMCS data

    May 1, 2013, 00:00
  • Cost impact of depofoam bupivacaine for the management of post-surgical pain

    May 1, 2013, 00:00
  • Comparison Of Patient Reported Outcomes (Pros) And Clinician Reported Outcomes (Cros) In Patients With Metastatic Brain Disease

    May 1, 2013, 00:00
  • Identifying schizophrenia patients at high-risk for antipsychotic nonadherence using the assessment for quality improvement and risk evaluation tool

    May 1, 2013, 00:00
  • Estimating an EQ-5D-3L value set in Singapore

    May 1, 2013, 00:00
  • The jointness box - evaluating individualized care potential from traditional trial data

    May 1, 2013, 00:00
  • Drivers of resource utilization in patients with autosomal dominant polycystic kidney disease

    May 1, 2013, 00:00
  • Assessment Of Physicians' Knowledge And Perceptions Towards Medicine Quality And Prices In Kabul, Afghanistan

    May 1, 2013, 00:00
  • Cost-Effectiveness Of Mometasone Furoate Nasal Spray In The Treatment Of Rhinosinusitis In Mexico

    May 1, 2013, 00:00
  • Euroqol (EQ-5D) health utility scores in post-traumatic stress disorder (PTSD) patients- Results from a doubly randomized preference trial (DRPT)

    May 1, 2013, 00:00
  • Budget Impact Evaluation Of A Vaccination With Campaign Program For Corporations Using Pneumococcal Conjugated Vaccine (Pcv) 13 Valent Versus Pneumococcal Polisaccharide Vaccine (Ppv) 23 With Paid Campaign For Older Adults

    May 1, 2013, 00:00
  • Potential Benefits Analysis Of Quadrivalent Influenza Vaccine (Qiv) On Influenza Disease Burden In The United Kingdom, Year By Year Analysis (2000-2010)

    May 1, 2013, 00:00
  • A Systematic Review Of Diagnostic Accuracy Of Fdg Pet/Pet-Ct For Fever Of Unknown Origin

    May 1, 2013, 00:00
  • The association of burn injuries and Pseudoephedrine sales

    May 1, 2013, 00:00
  • Predictors of medication non-adherence among young adults- Comparing two scales

    May 1, 2013, 00:00
  • The effect of including an opt-out option in discrete choice experiments

    May 1, 2013, 00:00
  • Impact of hurricane katrina on epilepsy patients in the louisiana medicaid population

    May 1, 2013, 00:00
  • Budget Impact Analysis Of Osteoporosis Drug Therapy Reimbursement Criteria Updates In Korea

    May 1, 2013, 00:00
  • Perceptions And Barriers To Participation In Clinical Research Of Primary Care Physicians

    May 1, 2013, 00:00
  • Examining the impact of EQ-5d and long-standing health conditions on subjective well-being

    May 1, 2013, 00:00
  • Abdominal Aortic Aneurysm Screening- How Many Life Years Lost From Underuse Of The Medicare Screening Benefit?

    May 1, 2013, 00:00
  • Surgery and biologic use pattern for patients with crohn's disease who initiated tnf antagonists in a managed care setting in the United States

    May 1, 2013, 00:00
  • Impact Of A Value-Based Copayment Waiver Benefit On Medication Adherence And Spending

    May 1, 2013, 00:00
  • Lessons From Voluntary Reporting Of Illinois Hospital Employee Seasonal Influenza Vaccination Rates (2009-2013)

    May 1, 2013, 00:00
  • Budget impact analysis of linezolid in the treatment of complicated skin and soft tissue infections (cssti) in chile – Public scenario

    May 1, 2013, 00:00
  • Drugs Associated With Adverse Drug Events In Children- Analysis Of The United States Fda Adverse Event Reporting System Database

    May 1, 2013, 00:00
  • Clinical and economic burden of complications associated with coronary artery bybass graft and/or valve surgery

    May 1, 2013, 00:00
  • Cost Effectiveness Of Budesonide/Formoterol Versus Fluticasone/Salmeterol From A Swedish Health Care Perspective Based On Real-World Effectiveness And Safety In Patients With Copd

    May 1, 2013, 00:00
  • Care pathway and cost for absssi subjects with antibiotic treatment in the united states- An analysis of a real world database

    May 1, 2013, 00:00
  • Trends Of Utilization Of And Spending On Anti-Tuberculosis Medications In The United States Medicaid Program From 1991 To 2011

    May 1, 2013, 00:00
  • Multiple sclerosis early treatment rates in united states veterans

    May 1, 2013, 00:00
  • Measurement of health related quality of life using EQ-5D in patients with stroke in India

    May 1, 2013, 00:00
  • Ifosfamide Treatment Of Patients With Soft Tissue Sarcoma- Health Care Utilization And Cost Implications

    May 1, 2013, 00:00
  • Treatment Patterns After Castration Resistant Prostate Cancer (Crpc) Diagnosis- A European Physician Survey

    May 1, 2013, 00:00
  • Health Economic Evidence In Support Of A Long-Acting Reversible Contraceptive Method- LNG-IUS-12, A Low-Dose Contraceptive Levonorgestrel Intrauterine System

    May 1, 2013, 00:00
  • Approvals And Market Discontinuations Of Oncology Drugs In The United States (1980-2012)

    May 1, 2013, 00:00
  • Health insurance cost of parkinson disease in Hungary- A cost of illness study

    May 1, 2013, 00:00
  • Estimating the payer-specific excess medical costs of opioid abuse in the United States

    May 1, 2013, 00:00
  • Reduction Of Pulmonary Arterial Hypertension (Pah)-Related Hospitalizations With Macitentan In The Randomized Controlled Trial Seraphin

    May 1, 2013, 00:00
  • Evaluation of the alopecia patient assessment (APA) questionnaire in women with breast cancer and alopecia

    May 1, 2013, 00:00
  • Prescription Drugs And Discounts- The Pharmacist's View

    May 1, 2013, 00:00
  • Lessons Learned From The Dedicated Oncology Drug Review Process In Canada

    May 1, 2013, 00:00
  • The Pharmacoeconomic And Health Related Quality Of Life In Rheumatoid Arthritis (Ra) Patients In A Tertiary Care Hospital

    May 1, 2013, 00:00
  • Examining Ontario's Universal Influenza Immunization Program With A New Dynamic Influenza Model

    May 1, 2013, 00:00
  • Cost-Effectiveness Of Bendamustine+Rituximab Versus Fludarabine+Rituximab In The Treatment Of Relapsed Indolent Non-Hodgkin's And Mantle Cell Lymphomas In Canada

    May 1, 2013, 00:00
  • Effect Of Insurance Coverage On Health-Care Expenditures Among Patients With Arthritis

    May 1, 2013, 00:00
  • Economic evaluation of a school clinic intervention to prevent rheumatic fever

    May 1, 2013, 00:00
  • Evaluating The Differential Impact Of Physical Versus Mental Co-Morbidities On The Health State Utilities Of Patients With Arthritis, Asthma, Diabetes And Migraine

    May 1, 2013, 00:00
  • Spontaneous reporting data- A global comparison using an online database resource

    May 1, 2013, 00:00
  • The expected value of sample information from the pharmaceutical perspective under conditions of value based pricing

    May 1, 2013, 00:00
  • Budgetary Impact Of Linaclotide In The Treatment Of Us Adult Patients With Irritable Bowel Syndrome With Constipation (Ibs-C) Or Chronic Constipation (Cc)

    May 1, 2013, 00:00
  • MPR AND PDC- IMPLICATIONS FOR INTERPRETATION OF ADHERENCE RESEARCH RESULTS

    May 1, 2013, 00:00
  • Estimating the association between QT prolongation and SSRI utilization from the FDA'S adverse event reports

    May 1, 2013, 00:00
  • A novel approach to ranking parameter uncertainty in one-way sensitivity analysis- What tornado diagrams are missing

    May 1, 2013, 00:00
  • Disease expenditure models and calibration methods on physician surveys

    May 1, 2013, 00:00
  • Cost-effectiveness analysis of biological therapies for the treatment of moderate and severe psoriasis in institutional market in Ecuador

    May 1, 2013, 00:00
  • Effects Of Pill Burden On Discontinuation Of The Initial Haart Regimen In Minority Female Patients Prescribed 1 Pill/Day Versus Any Other Regimen

    May 1, 2013, 00:00
  • Does An Eczema Diagnosis In Children Under The Age Of Three Predict A Severe Asthma Diagnosis- A Uk Retrospective Analysis?

    May 1, 2013, 00:00
  • Surfing The German Benefit Assessment Wave

    May 1, 2013, 00:00
  • Quality of life among diabetes patients

    May 1, 2013, 00:00
  • Health Technology Assessment And Value-Based Pricing In Germany, The United Kingdom And Fran Recent Developments And Implications

    May 1, 2013, 00:00
  • To Identify Comorbid Depression In Diabetes Patients And Comparing The Differences In Use Of Health Care Services In Diabetic Patients With And Without Comorbid Depression

    May 1, 2013, 00:00
  • Inter-Country Variability In Coverage Decisions For Orphan Drugs- Criteria Driving Hta Recommendations In Six Countries

    May 1, 2013, 00:00
  • The Costs Of Oral Versus Intravenous Chemotherapy In Insured, Low Income Patients With Breast Or Colon Cancer

    May 1, 2013, 00:00
  • Mapping relationships among pain descriptors used by patients- Evidence from qualitative interviews in four chronic pain conditions

    May 1, 2013, 00:00
  • Antibiotic prescribing patterns for community acquired pneumonia in hospitalized patients- A retrospective pilot study from delhi, india

    May 1, 2013, 00:00
  • Recent Trends In Type-2 Diabetes Mellitus-Related Inpatient Care Among Pediatric Patients In The United States

    May 1, 2013, 00:00
  • Cost-effectiveness of sapien® transcatheter aortic valve for severe symptomatic aortic stenosis in inoperable patients in the Brazilian public health care system

    May 1, 2013, 00:00
  • Non-Traditional Schemes Approach For Public Market Access Of End-Of-Life Treatments In Mexican Health Care System

    May 1, 2013, 00:00
  • Health Care Costs And Clinical Outcomes Associated With Rates Of Sulfonylurea Use By Physicians

    May 1, 2013, 00:00
  • Comparison of pharmacy based and diagnosis based indexes for predicting of the total health care expenditure among adult asthmatics

    May 1, 2013, 00:00
  • «
  • 111
  • 112
  • 113
  • 114 (current)
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • »